About us
- >
- About us >
- Information >
- Announcement
Announcement
-
2020-10-08The IND application of ENERGI-F703 for treating venous leg ulcers (VLU) has been approved by TFDA.
-
2020-09-21The Australian patent “Compounds for activating AMPK and the uses thereof.” is granted.
-
2020-06-24The Singapore patent “Compounds for activating AMPK and the uses thereof.” is granted.
-
2020-05-07The Turk patent “Composition for promoting hair growth” is granted
-
2020-05-07The Europe patent “Compounds for activating AMPK and the uses thereof.” is granted.
-
2020-03-18The Korean patent “Compounds for activating AMPK and the uses thereof.” is granted.
-
2020-03-16The phase II trial of ENERGI-F701, the solution for female hair loss treatment has completed the data analysis.
-
2019-12-17The Israeli patent “Compounds for activating AMPK and the uses thereof.” is granted
-
2019-11-08The IND application of ENERGI-F703 for treating venous leg ulcers (VLU) has been approved by the US FDA
-
2019-10-23The Phase II trial of ENERGI-F703 Diabetic Foot Ulcer Gel meets the primary endpoint. Energenesis is planning phase III clinical trials